We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Liquid-Based Cytology Is as Effective as Conventional Smears

By LabMedica International staff writers
Posted on 08 Nov 2010
Cervical cytology specimens are used to check abnormalities and are regularly used as a prophylactic test in gynecological examinations.

The routine Papanicolau (Pap) test has been compared to liquid based cytology to evaluate the efficiency and effectiveness of systems based on cytocentrifugation. The sensitivity and specificity of the liquid-based gynecological system was assessed.

In a study carried out at Vilnius University, (Vilnius, Lithuania), 2,945 women referred to prophylactic check-up were enrolled. Split sample design was used in 1,500 women and residual cervical cytology specimen from all these cases was placed in fluid for cytocentrifugation preparation after performing conventional smears. The centrifugation was performed in a low speed centrifugal force device called the Shandon PapSpin. The direct-to-vial study was carried out in another cohort of 1,445 women in whom the entire cervical material was investigated using only the PapSpin technique.

In the split sample group, conventional smears showed a higher proportion of atypical cells undetermined significance (ASC-US): 2.1% compared to 0.7% in the PapSpin samples. A higher proportion of unsatisfactory samples were found in the conventional smear group1.7% compared to 0.4% of cases in the device group. In the split sample group, the sensitivity of the conventional and PapSpin tests was 68.7% versus 78.1%, and the specificity 93.8% versus 91.8%, respectively. In the direct to vial group, PapSpin sensitivity was 75.9% and specificity 96.5%. The Shandon PapSpin is manufactured by Thermo Shandon (Pittsburgh, PA, USA).

The PapSpin method offers several advantages such as the opportunity to prepare duplicate slides, option for Human Papilloma Virus (HPV) DNA testing and cell block preparations from residual material. Microscopic evaluation of thinner cell preparations is less time consuming than the conventional Pap smears. The study was published online in March 2010, in Cytology Journal.

Related Links:
Vilnius University
Thermo Shandon



New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.